US Stock MarketDetailed Quotes

ACXP Acurx Pharmaceuticals

Watchlist
  • 0.825
  • +0.067+8.77%
Close Dec 20 16:00 ET
  • 0.825
  • 0.0000.00%
Post 20:01 ET
13.94MMarket Cap-0.76P/E (TTM)

Acurx Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-4.60%-2.19M
-82.68%-2.88M
-58.46%-3.06M
-29.95%-9.8M
-180.68%-4.2M
3.97%-2.09M
20.80%-1.58M
-3.03%-1.93M
-50.43%-7.54M
0.31%-1.5M
Net income from continuing operations
9.42%-2.82M
-19.64%-4.12M
-50.81%-4.38M
-20.55%-14.58M
-56.86%-5.11M
12.05%-3.11M
-31.47%-3.45M
-8.72%-2.9M
5.14%-12.09M
-24.11%-3.26M
Change In working capital
-12.22%165.19K
-98.96%11.05K
62.53%114.83K
-19.02%1.01M
-132.56%-310.15K
-64.99%188.19K
1,323.61%1.06M
145.57%70.65K
783.42%1.25M
159.70%952.46K
-Change in receivables
---46.25K
---51.13K
--129.16K
---129.16K
---129.16K
--0
--0
--0
--0
----
-Change in prepaid assets
388.88%45.59K
-83.28%19.5K
-240.75%-82.13K
424.50%159.18K
-100.07%-54
92.86%-15.78K
-4.84%116.66K
4.48%58.35K
112.30%30.35K
-69.04%72.85K
-Change in payables and accrued expense
-18.69%165.85K
-95.49%42.68K
451.39%67.8K
-19.46%980.75K
-120.57%-180.94K
-71.20%203.97K
694.05%945.43K
105.83%12.3K
213.88%1.22M
569.04%879.61K
Cash from discontinued investing activities
Operating cash flow
-4.60%-2.19M
-82.68%-2.88M
-58.46%-3.06M
-29.95%-9.8M
-180.68%-4.2M
3.97%-2.09M
20.80%-1.58M
-3.03%-1.93M
-50.43%-7.54M
0.31%-1.5M
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities
1.59M
-90.96%320.21K
4.51M
120.92%8.16M
461,963,800.00%4.62M
0
3.54M
0
-75.03%3.7M
-1
Net common stock issuance
144.91%1.59M
-90.96%320.21K
--4.3M
60.86%5.94M
--5.94M
---3.54M
--3.54M
--0
-75.03%3.7M
----
Proceeds from stock option exercised by employees
--0
--0
--210.2K
17,069,684.62%2.22M
--2.22M
--0
--73
--0
--13
--0
Cash from discontinued financing activities
Financing cash flow
--1.59M
-90.96%320.21K
--4.51M
120.92%8.16M
461,963,800.00%4.62M
--0
--3.54M
--0
-75.03%3.7M
---1
Net cash flow
Beginning cash position
-30.45%6.36M
24.27%8.92M
-17.97%7.47M
-29.69%9.11M
-33.51%7.05M
0.59%9.15M
-35.23%7.18M
-29.69%9.11M
308.10%12.96M
-26.64%10.61M
Current changes in cash
71.42%-598.29K
-230.15%-2.56M
174.85%1.45M
57.43%-1.64M
128.21%421.86K
-238.17%-2.09M
198.81%1.97M
-3.03%-1.93M
-139.32%-3.85M
0.31%-1.5M
End cash Position
-18.29%5.76M
-30.45%6.36M
24.27%8.92M
-17.97%7.47M
-17.97%7.47M
-33.51%7.05M
0.59%9.15M
-35.23%7.18M
-29.69%9.11M
-29.69%9.11M
Free cash flow
-4.60%-2.19M
-82.68%-2.88M
-58.46%-3.06M
-29.95%-9.8M
-180.68%-4.2M
3.97%-2.09M
20.80%-1.58M
-3.03%-1.93M
-50.43%-7.54M
0.31%-1.5M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -4.60%-2.19M-82.68%-2.88M-58.46%-3.06M-29.95%-9.8M-180.68%-4.2M3.97%-2.09M20.80%-1.58M-3.03%-1.93M-50.43%-7.54M0.31%-1.5M
Net income from continuing operations 9.42%-2.82M-19.64%-4.12M-50.81%-4.38M-20.55%-14.58M-56.86%-5.11M12.05%-3.11M-31.47%-3.45M-8.72%-2.9M5.14%-12.09M-24.11%-3.26M
Change In working capital -12.22%165.19K-98.96%11.05K62.53%114.83K-19.02%1.01M-132.56%-310.15K-64.99%188.19K1,323.61%1.06M145.57%70.65K783.42%1.25M159.70%952.46K
-Change in receivables ---46.25K---51.13K--129.16K---129.16K---129.16K--0--0--0--0----
-Change in prepaid assets 388.88%45.59K-83.28%19.5K-240.75%-82.13K424.50%159.18K-100.07%-5492.86%-15.78K-4.84%116.66K4.48%58.35K112.30%30.35K-69.04%72.85K
-Change in payables and accrued expense -18.69%165.85K-95.49%42.68K451.39%67.8K-19.46%980.75K-120.57%-180.94K-71.20%203.97K694.05%945.43K105.83%12.3K213.88%1.22M569.04%879.61K
Cash from discontinued investing activities
Operating cash flow -4.60%-2.19M-82.68%-2.88M-58.46%-3.06M-29.95%-9.8M-180.68%-4.2M3.97%-2.09M20.80%-1.58M-3.03%-1.93M-50.43%-7.54M0.31%-1.5M
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities 1.59M-90.96%320.21K4.51M120.92%8.16M461,963,800.00%4.62M03.54M0-75.03%3.7M-1
Net common stock issuance 144.91%1.59M-90.96%320.21K--4.3M60.86%5.94M--5.94M---3.54M--3.54M--0-75.03%3.7M----
Proceeds from stock option exercised by employees --0--0--210.2K17,069,684.62%2.22M--2.22M--0--73--0--13--0
Cash from discontinued financing activities
Financing cash flow --1.59M-90.96%320.21K--4.51M120.92%8.16M461,963,800.00%4.62M--0--3.54M--0-75.03%3.7M---1
Net cash flow
Beginning cash position -30.45%6.36M24.27%8.92M-17.97%7.47M-29.69%9.11M-33.51%7.05M0.59%9.15M-35.23%7.18M-29.69%9.11M308.10%12.96M-26.64%10.61M
Current changes in cash 71.42%-598.29K-230.15%-2.56M174.85%1.45M57.43%-1.64M128.21%421.86K-238.17%-2.09M198.81%1.97M-3.03%-1.93M-139.32%-3.85M0.31%-1.5M
End cash Position -18.29%5.76M-30.45%6.36M24.27%8.92M-17.97%7.47M-17.97%7.47M-33.51%7.05M0.59%9.15M-35.23%7.18M-29.69%9.11M-29.69%9.11M
Free cash flow -4.60%-2.19M-82.68%-2.88M-58.46%-3.06M-29.95%-9.8M-180.68%-4.2M3.97%-2.09M20.80%-1.58M-3.03%-1.93M-50.43%-7.54M0.31%-1.5M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--
Heat List
US
Overall
Symbol
Price
% Chg

No Data